share_log

Ginkgo Bioworks | 10-Q: Q1 2024 Earnings Report

Ginkgo Bioworks | 10-Q: Q1 2024 Earnings Report

Ginkgo Bioworks | 10-Q:2024財年一季報
美股SEC公告 ·  05/09 16:22

Moomoo AI 已提取核心訊息

Ginkgo Bioworks Holdings, Inc. reported a decrease in total revenue for the first quarter ended March 31, 2024, with revenues falling to $37.944 million from $80.702 million in the same period last year. The company's Cell Engineering segment saw a decrease in revenue from $34.096 million to $27.889 million, while the Biosecurity segment's revenue dropped significantly from $46.606 million to $10.055 million. The total segment operating loss widened to $123.662 million from $116.410 million year-over-year. The diluted net loss per share remained constant at $0.08, improving from a net loss of $0.11 per share in the previous year. Ginkgo Bioworks also reported a net loss of $165.911 million, an improvement from a net loss of $204.969 million in the first quarter of 2023. The company has undertaken restructuring actions to reduce...Show More
Ginkgo Bioworks Holdings, Inc. reported a decrease in total revenue for the first quarter ended March 31, 2024, with revenues falling to $37.944 million from $80.702 million in the same period last year. The company's Cell Engineering segment saw a decrease in revenue from $34.096 million to $27.889 million, while the Biosecurity segment's revenue dropped significantly from $46.606 million to $10.055 million. The total segment operating loss widened to $123.662 million from $116.410 million year-over-year. The diluted net loss per share remained constant at $0.08, improving from a net loss of $0.11 per share in the previous year. Ginkgo Bioworks also reported a net loss of $165.911 million, an improvement from a net loss of $204.969 million in the first quarter of 2023. The company has undertaken restructuring actions to reduce operational expenditures, including labor expense reductions and facility consolidations, expected to commence in the second quarter of 2024. Additionally, Ginkgo acquired platform assets from AgBiome, Inc. on April 10, 2024, to enhance its Ag Biologicals Services. Looking forward, Ginkgo Bioworks aims to leverage its Foundry and Codebase assets to drive scale and learning efficiencies across diverse markets, with a focus on improving the probability of successful product development for its customers.
Ginkgo Bioworks Holdings, Inc.報告稱,截至2024年3月31日的第一季度總營業收入下降,收入從去年同期的8080.2萬美元降至3794.4萬美元。該公司的電芯工程業務收入從3409.6萬美元下降至2788.9萬美元,而生物安全業務的收入從4660.6萬美元急劇下降至1005.5萬美元。總部門運營虧損從去年同期的11641萬美元擴大至12366.2萬美元。稀釋淨虧損每股保持不變,爲0.08美元,較上年同期每股淨虧損0.11美元有所改善。Ginkgo Bioworks的淨虧損也從2023年第一季度的20496.9萬美元有所改善,下降至16591.1萬美元。該公司已經採...展開全部
Ginkgo Bioworks Holdings, Inc.報告稱,截至2024年3月31日的第一季度總營業收入下降,收入從去年同期的8080.2萬美元降至3794.4萬美元。該公司的電芯工程業務收入從3409.6萬美元下降至2788.9萬美元,而生物安全業務的收入從4660.6萬美元急劇下降至1005.5萬美元。總部門運營虧損從去年同期的11641萬美元擴大至12366.2萬美元。稀釋淨虧損每股保持不變,爲0.08美元,較上年同期每股淨虧損0.11美元有所改善。Ginkgo Bioworks的淨虧損也從2023年第一季度的20496.9萬美元有所改善,下降至16591.1萬美元。該公司已經採取重組行動以降低運營支出,包括削減勞動力費用和設施整合,預計將於2024年第二季度開始。此外,Ginkgo於2024年4月10日收購了AgBiome,Inc的平台資產,以增強其農業生物服務。未來,Ginkgo Bioworks旨在利用其Foundry和Codebase資產,在不同的市場上推動規模和學習效率,關注提高客戶產品開發成功率。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息